Original Literature | Model OverView |
---|---|
Publication
Title
A pervasive role of ubiquitin conjugation in activation and termination ofIkappaB kinase pathways.
Affiliation
Max-Delbruck-Center for Molecular Medicine, Robert-Rossle-Strasse 10, D-13122Berlin, Germany.
Abstract
The nuclear factor (NF)-kappaB pathway is a paradigm for gene expression controlby ubiquitin-mediated protein degradation. In stimulated cells, phosphorylationby the IkappaB kinase (IKK) complex primes NF-kappaB-inhibiting IkappaBmolecules for lysine (Lys)-48-linked polyubiquitination and subsequentdestruction by the 26S proteasome. However, recent studies indicate that theubiquitin (Ub) system controls NF-kappaB pathways at many levels. Ub ligases areactivated by different upstream signalling pathways, and they function ascentral regulators of IKK and c-Jun amino-terminal kinase activation. Theassembly of Lys 63 polyUb chains provides docking surfaces for the recruitmentof IKK-activating complexes, a reaction that is counteracted by deubiquitinatingenzymes. Furthermore, Ub conjugation targets upstream signalling mediators aswell as nuclear NF-kappaB for post-inductive degradation to limit the durationof signalling.
PMID
15809659
|
Entity
RIP
--
MO000000208
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m179
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000208 |
--
TRAF2
--
MO000000209
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m180
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000209 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IKKalpha:IKK-beta:IKK-gamma
--
MO000000248
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m207
10
infinite
0
TRANSPATH | MO000000248 |
--
A20
--
MO000016591
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1585
10
infinite
0
InterPro | IPR002653 |
TRANSPATH | MO000016591 |
--
p50:RelA-p65{active}
--
MO000016632
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1617
10
infinite
0
TRANSPATH | MO000016632 |
--
TRAF6{ub} oligomer
--
MO000016963
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1872
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000016963 |
--
Nedd4
--
MO000017913
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2654
10
infinite
0
TRANSPATH | MO000017913 |
--
Ubc13
--
MO000022136
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6443
10
infinite
0
InterPro | IPR000608 |
TRANSPATH | MO000022136 |
--
p62
--
MO000022281
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6578
10
infinite
0
InterPro | IPR000433 |
TRANSPATH | MO000022281 |
--
p50:RelA-p65:IkappaB
--
MO000038724
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16910
10
infinite
0
TRANSPATH | MO000038724 |
--
CYLD
--
MO000041169
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19042
10
infinite
0
TRANSPATH | MO000041169 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
protein remnants
--
e10
cso30:c:EntityBiological
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m10
0
infinite
0
--
RIP{ub}
--
e11
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m11
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000208 |
--
TAK1:TAB2:TAB3
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
TRAF2{ub}:TAK1:TAB2:TAB3
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
RIP{ub}:TAK1:TAB2:TAB3
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
IKKalpha:IKKbeta{p}:IKK-gamma
--
e16
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16
10
infinite
0
TRANSPATH | MO000000248 |
--
IL-1:IL-1R
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
Ligand:TLR
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
TRAF6{ub}
--
e19
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TIFA
--
e20
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
IKKalpha:IKk-beta:IKK-gamma{ub}
--
e21
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m22
10
infinite
0
TRANSPATH | MO000000248 |
--
TRAF6{ub} oligomer:TAK1:TAB2:TAB3
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
IKKalpha:IKk-beta{p}:IKK-gamma{ub}
--
e23
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m24
10
infinite
0
TRANSPATH | MO000000248 |
--
p50:RelA-p65:IkappaB{p}
--
e24
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m25
10
infinite
0
TRANSPATH | MO000038724 |
--
BetaTRCP
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
p50:RelA-p65:IkappaB{p}{ub}
--
e26
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m27
10
infinite
0
TRANSPATH | MO000038724 |
--
PLIC
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
Cezanne
--
e28
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m29
0
infinite
0
--
Ligand:TCR
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
PLCgamma{active}
--
e30
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m31
10
infinite
0
TRANSPATH | MO000000102 |
--
PKCdelta{active}
--
e31
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m32
10
infinite
0
TRANSPATH | MO000000134 |
--
BCL10
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
CARMA1
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
BCL10:MALT1:CARMA1
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
BCL10:MALT1 oligomer:CARMA1
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
Bacteria
--
e36
cso30:c:Cell
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
Nod2:Bacteria
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
TRABID
--
e38
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m39
0
infinite
0
--
TRAF6:Cezanna
--
e39
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
TRAF6:TRABID
--
e40
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m41
0
infinite
0
--
TNFR1
--
e41
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m42
0
infinite
0
--
csml-variable:Double
m43
0
infinite
0
--
TNFRII
--
e43
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m44
0
infinite
0
--
c-IAP1
--
e44
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m45
0
infinite
0
--
c-IAP1
--
e45
cso30:c:mRNA
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m46
0
infinite
0
--
Ligand:CD28
--
e48
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m49
0
infinite
0
--
BCL10{ub}
--
e49
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
TNF-alpha:TNFR
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TRAF2{ub}
--
e6
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000209 |
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
p62:IKK-alpha:IKK-beta:IKK-gamma{uba]
--
e63
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m64
0
infinite
0
--
p62:RIP{ub}
--
e64
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m65
0
infinite
0
--
TRAF2{ub}:p62
--
e65
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m66
0
infinite
0
--
TRAF6{ub}:p62
--
e66
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m67
0
infinite
0
--
csml-variable:Double
m68
0
infinite
0
--
csml-variable:Double
m69
0
infinite
0
--
protein degradants
--
e69
cso30:c:EntityBiological
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
SOCS-1:p50:RelA-p65{active}
--
e70
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m71
0
infinite
0
--
SOCS-1:p50:RelA-p65{ub}
--
e71
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m72
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c7 : 1
stoichiometry:c3 : 1
m5*m180*m6443*0.1
nodelay
--
0
PMID: 15809659,12591926 TRAF2 and TRAF5 also contain a RING domain and UbLys63 modifications can be detected in TRAF2 on TNF-alpha stimulation
p10
p10
cso30:i:ME_Oligomerization
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m19*m20*0.1
nodelay
--
0
PMID: 15809659,11460167 TRAF6 undergoes trans-auto-ubiquitination , which is strongly enhanced by its forced oligomerization PMID: 15809659,15492226 TRAF-interacting protein with forkhead-associated domain (TIFA) oligomers promote TRAF6 oligomerization and Ub ligase activity
p11
p11
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m207*m1872*0.1
nodelay
--
0
PMID: 15809659,11460167 TRAF6 undergoes trans-auto-ubiquitination , which is strongly enhanced by its forced oligomerization PMID: 15809659,15492226 TRAF-interacting protein with forkhead-associated domain (TIFA) oligomers promote TRAF6 oligomerization and Ub ligase activity
p3
p12
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m19*m21*0.1
nodelay
--
0
PMID: 15809659,12591926,11460167 Both TRAF2 and TRAF6 activate c-Jun amino-terminal kinase (JNK) in parallel to IKK, in a process that also depends on the assembly of UbLys63 chains
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m13*m1872*0.1
nodelay
--
0
PMID: 15809659 Figure 2A PMID: 15809659 Ubiquitin (Ub) ligases (shown in green) catalyse the assembly of UbLys63 chains (green) on TRAF2, TRAF6, RIP and IKK-gamma, which is thought to recruit the protein kinase TAK1 through association with TAB2 or TAB3.
p14
p14
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m16*m16910*0.1
nodelay
--
0
PMID: 15809659 Figure 2A
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m22*m23*0.1
nodelay
--
0
PMID: 15809659 TAK1 activates the IKK complex, which subsequently targets IkappaBs for BetaTrCP-mediated UbLys48 modification. PMID: 15809659 Figure 2A
p14
p16
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m24*m16910*0.1
nodelay
--
0
PMID: 15809659 Figure 2A
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m26*m25*0.1
nodelay
--
0
PMID: 15809659 TAK1 activates the IKK complex, which subsequently targets IkappaBs for BetaTrCP-mediated UbLys48 modification.
p18
p18
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c102 : 1
m27*m28*0.1
nodelay
--
0
PMID: 15809659 Figure 2A PMID: 15809659,10983987 The ubiquitin-like PLIC may provide a link between the ubiquitination machinery and the proteasome
p19
p19
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m30*m90*0.1
nodelay
--
0
PMID: 15809659 Figure2A
p2
p2
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m180*m179*0.1
nodelay
--
0
PMID: 15809659,15258597 In addition, TRAF2 catalyses Lys 63 polyubiquitination of receptor-interacting protein (RIP)
p19
p20
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m31*m121*0.1
nodelay
--
0
PMID: 15809659 Figure2A PMID: 15809659,15122200 T-cell receptor (TCR) ligation triggers protein kinase Cdelta (PKCdelta)-mediated formation of a complex that consists of the CARMA1 (caspase recruitment domain-containing membrane-associated guanylate kinase protein 1), B-cell lymphoma 10 (BCL10) and mucosa-associated lymphoid tissue (MALT1) proteins and transmits the signal to the IKK complex
p21
p21
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c66 : 1
stoichiometry:c65 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m32*m38297*m33*m34*0.1
nodelay
--
0
MID: 15809659,15122200 T-cell receptor (TCR) ligation triggers protein kinase Cdelta (PKCdelta)-mediated formation of a complex that consists of the CARMA1 (caspase recruitment domain-containing membrane-associated guanylate kinase protein 1), B-cell lymphoma 10 (BCL10) and mucosa-associated lymphoid tissue (MALT1) proteins and transmits the signal to the IKK complex
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m35*m207*0.1
nodelay
--
0
PMID: 15809659,15125833 BCL10 and MALT1 can induce E3 activity of TRAF6, and RNA interference (RNAi) suggests that TRAF2 and TRAF6 are necessary for IKK activation in Jurkat T cells after TCR ligation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m35*0.1
nodelay
--
0
PMID: 15809659,11262391 BCL10 induces oligomerization of MALT1 which might enhance its Ub ligase activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m36*m207*0.1
nodelay
--
0
PMID: 15809659,14695475 MALT1 triggers UbLys63 modification of Lys 399 in the carboxy-terminal zinc-finger domain of IKKgamma; mutation of this residue abolishes IKK/NF-KappaB activation by BCL10
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m37*m4947*0.1
nodelay
--
0
PMID: 15809659,15620648 Nucleotide-binding oligomerization domain 2 (NOD2), which functions as an intracellular sensor for bacteria, promotes RIP2-dependent NF-¦ÊB activation by inducing the assembly of Lys 63 polyUb chains at position Lys 285 of IKKgamma
p26
p26
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m38*m2684*m207*0.1
nodelay
--
0
PMID: 15809659,15620648 Nucleotide-binding oligomerization domain 2 (NOD2), which functions as an intracellular sensor for bacteria, promotes RIP2-dependent NF-¦ÊB activation by inducing the assembly of Lys 63 polyUb chains at position Lys 285 of IKKgamma
p27
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c84 : 1
stoichiometry:c86 : 1
m16910*m22*0.1
nodelay
--
0
PMID: 15809659,15620648 Nucleotide-binding oligomerization domain 2 (NOD2), which functions as an intracellular sensor for bacteria, promotes RIP2-dependent NF-¦ÊB activation by inducing the assembly of Lys 63 polyUb chains at position Lys 285 of IKKgamma
p28
p28
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m1617*0.1
nodelay
--
0
PMID: 15809659,15226292 Expression of CYLD is induced by NF-KappaB, which provides a novel autoregulatory feedback pathway that could limit the duration of IKK activity
p29
p29
cso30:i:ME_Cleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m19042*m6*0.1
nodelay
--
0
PMID: 15809659,12917690,12917691,12917689 CYLD interferes with IKK/NF-KappaB signalling by catalysing the selective cleavage of UbLys63 chains from TRAF2, TRAF6 and IKKgamma, without affecting UbLys48-modified IKappaBalpha or Beta-catenin
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c10 : 1
m6*m21*0.1
nodelay
--
0
PMID: 15809659,12591926,11460167 Both TRAF2 and TRAF6 activate c-Jun amino-terminal kinase (JNK) in parallel to IKK, in a process that also depends on the assembly of UbLys63 chains
p29
p30
cso30:i:ME_Cleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m19042*m19*0.1
nodelay
--
0
PMID: 15809659,12917690,12917691,12917689 CYLD interferes with IKK/NF-KappaB signalling by catalysing the selective cleavage of UbLys63 chains from TRAF2, TRAF6 and IKKgamma, without affecting UbLys48-modified IKappaBalpha or Beta-catenin
p29
p31
cso30:i:ME_Cleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m19042*m22*0.1
nodelay
--
0
PMID: 15809659,12917690,12917691,12917689 CYLD interferes with IKK/NF-KappaB signalling by catalysing the selective cleavage of UbLys63 chains from TRAF2, TRAF6 and IKKgamma, without affecting UbLys48-modified IKappaBalpha or Beta-catenin
p32
p32
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m5*m16910*0.1
nodelay
--
0
PMID: 15809659 Overexpression of CYLD represses NF-KappaB activation in response to various stimuli, including TNF and IL-1.
p32
p33
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c109 : 1
stoichiometry:c108 : 1
m17*m16910*0.1
nodelay
--
0
PMID: 15809659 Overexpression of CYLD represses NF-KappaB activation in response to various stimuli, including TNF and IL-1.
p34
p34
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m1585*m11*0.1
nodelay
--
0
PMID: 15809659,15334086,15258597 The N-terminal ovarian tumour (OTU) domain of A20 contains DUB activity and catalyses the removal of UbLys63 chains from RIP and TRAF6, thereby interfering with TNFR and TLR signalling to IKKs/NF-KappaB, respectively
p34
p35
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m1585*m19*0.1
nodelay
--
0
PMID: 15809659,15334086,15258597 The N-terminal ovarian tumour (OTU) domain of A20 contains DUB activity and catalyses the removal of UbLys63 chains from RIP and TRAF6, thereby interfering with TNFR and TLR signalling to IKKs/NF-KappaB, respectively
p36
p36
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c129 : 1
stoichiometry:c118 : 1
m1585*m179*m5*0.1
nodelay
--
0
PMID: 15809659,15258597 Subsequently, the C-terminal zinc-finger domain functions as a Ub ligase that mediates UbLys48 modification of RIP and initiates its proteasomal degradation PMID: 15809659 Figure2B PMID: 15809659,12753742,15258597 Binding of TNF-alpha to TNFRI induces ubiquitination and degradation of RIP after recruitment to lipid rafts with A20 acting as the potential Ub ligase in this reaction
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m11*0.1
nodelay
--
0
PMID: 15809659,15258597 Subsequently, the C-terminal zinc-finger domain functions as a Ub ligase that mediates UbLys48 modification of RIP and initiates its proteasomal degradation PMID: 15809659 Figure2B PMID: 15809659,11907583 TNFRII-dependent process that requires the cellular inhibitor of apoptosis protein (c-IAP1) as a Ub ligase, TRAF2 is polyubiquitinated and degraded as well
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m183*m29*0.1
nodelay
--
0
PMID: 15809659,11463333 Using sequence similarity, Cezanne and TRAF-binding domain (TRABID) have been isolated as two further potential DUBs that contain OTU domains and can interact with TRAF6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m183*m39*0.1
nodelay
--
0
PMID: 15809659,11463333 Using sequence similarity, Cezanne and TRAF-binding domain (TRABID) have been isolated as two further potential DUBs that contain OTU domains and can interact with TRAF6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c12 : 1
stoichiometry:c13 : 1
m6*m13*0.1
nodelay
--
0
PMID: 15809659 Figure 2A PMID: 15809659 Ubiquitin (Ub) ligases (shown in green) catalyse the assembly of UbLys63 chains (green) on TRAF2, TRAF6, RIP and IKK-gamma, which is thought to recruit the protein kinase TAK1 through association with TAB2 or TAB3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
1.0*0.1
nodelay
--
0
PMID: 15809659 Ectopic expression of Cezanne downregulates NF-¦ÊB, which suggests that Cezanne interferes with IKK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m230*m42*0.1
nodelay
--
0
PMID: 15809659,12753742,15258597 Binding of TNF-alpha to TNFRI induces ubiquitination and degradation of RIP after recruitment to lipid rafts with A20 acting as the potential Ub ligase in this reaction
p42
p42
cso30:i:ME_Ubiquitination
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c134 : 1
stoichiometry:c136 : 1
stoichiometry:c135 : 1
m44*m179*m45*0.1
nodelay
--
0
PMID: 15809659,11907583 TNFRII-dependent process that requires the cellular inhibitor of apoptosis protein (c-IAP1) as a Ub ligase, TRAF2 is polyubiquitinated and degraded as well
p42
p43
cso30:i:ME_Ubiquitination
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c138 : 1
stoichiometry:c139 : 1
stoichiometry:c140 : 1
m44*m45*m180*0.1
nodelay
--
0
PMID: 15809659,11907583 TNFRII-dependent process that requires the cellular inhibitor of apoptosis protein (c-IAP1) as a Ub ligase, TRAF2 is polyubiquitinated and degraded as well
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c142 : 1
m6*0.1
nodelay
--
0
PMID: 15809659 Figure 2B PMID: 15809659,11907583 TNFRII-dependent process that requires the cellular inhibitor of apoptosis protein (c-IAP1) as a Ub ligase, TRAF2 is polyubiquitinated and degraded as well
p45
p45
cso30:i:ME_GeneExpression
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c144 : 1
m1617*0.1
nodelay
--
0
PMID: 15809659 Both gene products, A20 and c-IAP1, are upregulated by NF-¦ÊB, which indicates that an autoregulatory circuit shuts down TNF signalling in a post-inductive manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m1617*0.1
nodelay
--
0
PMID: 15809659 Both gene products, A20 and c-IAP1, are upregulated by NF-¦ÊB, which indicates that an autoregulatory circuit shuts down TNF signalling in a post-inductive manner.
p47
p47
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c149 : 1
m16459*m31*0.1
nodelay
--
0
PMID: 15809659 Itch, the Ub ligase homologue to the E6-AP C-terminal (HECT) domain, and the closely related Nedd4 protein promote ubiquitination and degradation of phospholipase Cgamma1 (PLCgamma1) and PKCdelta, both of which are essential mediators of IKK/NF-KappaB activation in T cells.
p53
p48
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
m48*0.1
nodelay
--
0
PMID: 15809659 Itch, the Ub ligase homologue to the E6-AP C-terminal (HECT) domain, and the closely related Nedd4 protein promote ubiquitination and degradation of phospholipase Cgamma1 (PLCgamma1) and PKCdelta, both of which are essential mediators of IKK/NF-KappaB activation in T cells.
p47
p49
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m16459*m32*0.1
nodelay
--
0
PMID: 15809659 Itch, the Ub ligase homologue to the E6-AP C-terminal (HECT) domain, and the closely related Nedd4 protein promote ubiquitination and degradation of phospholipase Cgamma1 (PLCgamma1) and PKCdelta, both of which are essential mediators of IKK/NF-KappaB activation in T cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c15 : 1
stoichiometry:c16 : 1
m11*m13*0.1
nodelay
--
0
PMID: 15809659 Figure 2A PMID: 15809659 Ubiquitin (Ub) ligases (shown in green) catalyse the assembly of UbLys63 chains (green) on TRAF2, TRAF6, RIP and IKK-gamma, which is thought to recruit the protein kinase TAK1 through association with TAB2 or TAB3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c164 : 1
stoichiometry:c165 : 1
stoichiometry:c166 : 1
m30*m49*m33*0.1
nodelay
--
0
PMID: 15809659,15082780 Similarly, BCL10, which is downstream of PKC¦È on the route to IKKs, is modified by ubiquitination and subsequently degraded after TCR/CD28 costimulation of T cells
p47
p51
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c158 : 1
stoichiometry:c159 : 1
m2654*m31*0.1
nodelay
--
0
PMID: 15809659 Itch, the Ub ligase homologue to the E6-AP C-terminal (HECT) domain, and the closely related Nedd4 protein promote ubiquitination and degradation of phospholipase Cgamma1 (PLCgamma1) and PKCdelta, both of which are essential mediators of IKK/NF-KappaB activation in T cells.
p47
p52
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c161 : 1
stoichiometry:c162 : 1
m2654*m32*0.1
nodelay
--
0
PMID: 15809659 Itch, the Ub ligase homologue to the E6-AP C-terminal (HECT) domain, and the closely related Nedd4 protein promote ubiquitination and degradation of phospholipase Cgamma1 (PLCgamma1) and PKCdelta, both of which are essential mediators of IKK/NF-KappaB activation in T cells.
p53
p53
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m47*0.1
nodelay
--
0
PMID: 15809659 Itch, the Ub ligase homologue to the E6-AP C-terminal (HECT) domain, and the closely related Nedd4 protein promote ubiquitination and degradation of phospholipase Cgamma1 (PLCgamma1) and PKCdelta, both of which are essential mediators of IKK/NF-KappaB activation in T cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c167 : 1
stoichiometry:c168 : 1
m63*0.1
nodelay
--
0
PMID: 15809659,15082780 Similarly, BCL10, which is downstream of PKC¦È on the route to IKKs, is modified by ubiquitination and subsequently degraded after TCR/CD28 costimulation of T cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c170 : 1
stoichiometry:c171 : 1
m6578*m22*0.1
nodelay
--
0
PMID: 15909659,15340068 p62 interacts through its UBA domain selectively with UbLys63-modified proteins, including TRAF6, while the N-terminal Phox and Bem1 (PB1) region provides a docking surface for the proteasome
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c173 : 1
stoichiometry:c174 : 1
m6578*m11*0.1
nodelay
--
0
PMID: 15909659,15340068 p62 interacts through its UBA domain selectively with UbLys63-modified proteins, including TRAF6, while the N-terminal Phox and Bem1 (PB1) region provides a docking surface for the proteasome
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c175 : 1
stoichiometry:c176 : 1
stoichiometry:c177 : 1
m6578*m6*0.1
nodelay
--
0
PMID: 15909659,15340068 p62 interacts through its UBA domain selectively with UbLys63-modified proteins, including TRAF6, while the N-terminal Phox and Bem1 (PB1) region provides a docking surface for the proteasome
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c179 : 1
stoichiometry:c180 : 1
m6578*m19*0.1
nodelay
--
0
PMID: 15809659,15340068 p62 interacts through its UBA domain selectively with UbLys63-modified proteins, including TRAF6, while the N-terminal Phox and Bem1 (PB1) region provides a docking surface for the proteasome
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c182 : 1
stoichiometry:c183 : 1
m5*m68*0.1
nodelay
--
0
PMID: 15809659,14690596,15226358 After TNF-alpha stimulation, DNA-bound p65 is subject to ubiquitination and proteasomal degradation in the nucleus¡½a process that seems to be required for abrogation of NF-kappaB activity despite IKappaBalpha re-synthesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m15*m207*0.1
nodelay
--
0
PMID: 15809659 TAK1 activates the IKK complex, which subsequently targets IkappaBs for BetaTrCP-mediated UbLys48 modification. PMID: 15809659 Figure 2A
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c185 : 1
m69*0.1
nodelay
--
0
PMID: 15809659,14690596,15226358 After TNF-alpha stimulation, DNA-bound p65 is subject to ubiquitination and proteasomal degradation in the nucleus¡½a process that seems to be required for abrogation of NF-kappaB activity despite IKappaBalpha re-synthesis
p61
p61
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c187 : 1
stoichiometry:c189 : 1
stoichiometry:c188 : 1
m1617*m1906*m155666*0.1
nodelay
--
0
PMID: 15809659,14690596 It has also been shown that suppressor of cytokine signalling 1 (SOCS1) associates with p65 in LPS-treated cells; the C-terminal SOCS domain functions as an E3 ligase to catalyse the poly-ubiquitination of p65 and its subsequent degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
m71*0.1
nodelay
--
0
PMID: 15809659,14690596 It has also been shown that suppressor of cytokine signalling 1 (SOCS1) associates with p65 in LPS-treated cells; the C-terminal SOCS domain functions as an E3 ligase to catalyse the poly-ubiquitination of p65 and its subsequent degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c192 : 1
stoichiometry:c193 : 1
m72*0.1
nodelay
--
0
PMID: 15809659,14690596 It has also been shown that suppressor of cytokine signalling 1 (SOCS1) associates with p65 in LPS-treated cells; the C-terminal SOCS domain functions as an E3 ligase to catalyse the poly-ubiquitination of p65 and its subsequent degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m14*m207*0.1
nodelay
--
0
PMID: 15809659 TAK1 activates the IKK complex, which subsequently targets IkappaBs for BetaTrCP-mediated UbLys48 modification. PMID: 15809659 Figure 2A
p8
p8
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m17*m6443*m183*0.1
nodelay
--
0
PMID: 15809659,10215628 Genetic ablation has demonstrated an essential function of TRAF6 in IKK activation through IL-1 receptor (IL-1R) and Toll-like receptor (TLR) signalling PMID: 15809659,11460167 TRAF6 undergoes trans-auto-ubiquitination , which is strongly enhanced by its forced oligomerization PMID: 15809659 Figure 2A
p8
p9
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
stoichiometry:c30 : 1
stoichiometry:c29 : 1
m18*m183*m6443*0.1
nodelay
--
0
PMID: 15809659,10215628 Genetic ablation has demonstrated an essential function of TRAF6 in IKK activation through IL-1 receptor (IL-1R) and Toll-like receptor (TLR) signalling PMID: 15809659,11460167 TRAF6 undergoes trans-auto-ubiquitination , which is strongly enhanced by its forced oligomerization PMID: 15809659 Figure 2A
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--